Close Menu

NEW YORK (GenomeWeb) – A new study suggests that it may be feasible to use differentially expressed microRNAs as a window for predicting prostate cancer recurrence in individuals treated with radical prostatectomy surgery.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.